Synthesis of sulfoximines and sulfilimines with aryl and pyrazolylmethyl substituents

Advanced Synthesis and Catalysis

Volumn 352, Issue 2-3, 2010, Pages 309-316

  Mancheño, Olga García ^a,b   Dallimore, Jonathan ^c   Plant, Andrew ^c   Bolm, Carsten ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Heterocycles; Imination; Iron catalysis; Metal free conditions; Sulfoximines

Indexed keywords

EID: 77149125543     PISSN: 16154150     EISSN: 16154169     Source Type: Journal    
DOI: 10.1002/adsc.200900729     Document Type: Article

References (89)

1. Reviews: a) M. Harmata, Chemtracts 2003, 16, 660-666;
2. b) H. Okamura, C. Bolm, Chem. Lett. 2004, 33, 482-487;
3. c) C. Bolm, in: Asymmetric Synthesis with Chemical and Biological Methods, (Eds.: D. Enders, K.-E. Jaeger), Wiley-VCH, Weinheim, Germany, 2007, pp 149 - 176;
4. d) C. Worch, A. C. Mayer, C. Bolm, in: Organosulfur Chemistry in Asymmetric Synthesis, (Eds.: T. Toru, C. Bolm), Wiley-VCH, Weinheim, Germany, 2008, pp 209 - 232. For recent examples, see:
5. e) S.-M. Lu, C. Bolm, Adv. Synth. Catal. 2008, 350, 1101-1105;
6. f) S.-M. Lu, C. Bolm, Chem. Eur. J. 2008, 14, 7513-7516;
7. g) S.-M. Lu, C. Bolm, Angew. Chem. 2008, 120, 9052-9055;
8. Angew. Chem. Int. Ed. 2008, 47, 8920-8923;
9. h) M. Frings, I. Atodiresei, J. Runsink, G. Raabe, C. Bolm, Chem. Eur. J. 2009, 15, 1566-1569.
10. a) C. Bolm, J. D. Kahmann, G. Moll, Tetrahedron Lett. 1997, 38, 1169-1172;
11. b) C. Bolm, G. Moll, J. D. Kahmann, Chem. Eur. J. 2001, 7, 1118-1128;
12. c) H. Tye, C. L. Skinner, Helv. Chim. Acta 2002, 85, 3272-3282;
13. d) C. Bolm, D. Müller, C. P. R. Hackenberger, Org. Lett. 2002, 4, 893-896;
14. e) C. Bolm, D. Müller, C. Dalhoff, C. P. R. Hackenberger, E. Weinhold, Bioorg. Med. Chem. Lett. 2003, 13, 3207-3211.
15. For recent examples of the patent literature related to agrochemicals, see: a) A. Jeanguenat, A. C. O'Sullivan, (Syngenta), Patent WO 032462A1, 2006;
16. b) A. Jeanguenat, A. C. O'Sullivan, (Syngenta), Patent WO 061200A1, 2006;
17. c) A. Plant, J. E. Boehmer, A. L. Peace, (Syngenta), Patent WO 037945A1, 2006;
18. d)Y. Zhu, R. B. Rogers, J. X. Huang, (Dow Agrosciences), U.S. Patent 0228027A1, 2005;
19. e) J. X. Huang, R. B. Rogers, N. Orr, T. C. Sparks, J. M. Gifford, M. R. Loso, Y. Zhu, T. Meade, (Dow Agrosciences), Patent WO 149134A1, 2007;
20. f) M. R. Loso, B. M. Nugent, J. X. Huang, (Dow Agrosciences), Patent WO 027073A1, 2008;
21. g) M. R. Loso, B. M. Nugent, Y. Zhu, T. L. Siddall, F. E. Tisdell, J. X. Huang, Z. L. Benko, (Dow Agrosciences), Patent WO 027539A1, 2008;
22. h) Y. Zhu, M. R. Loso, B. M. Nugent, J. X. Huang, R. B. Rogers, (Dow Agrosciences), Patent WO 057129A1, 2008.
23. For recent examples related to pharmaceuticals, see: a) M. Kahraman, S. Sinishtaj, P. M. Dolan, T. W. Kensler, S. Peleg, U. Saha, S. S. Chuang, G. Bernstein, B. Korczak, G. H. Posner, J. Med. Chem. 2004, 47, 6854-6863;
24. b) D. Lu, R. Vince, Bioorg. Med. Chem. Lett. 2007, 17, 5614-5619;
25. c) A. Raza, Y. Y. Sham, R. Vince, Bioorg. Med. Chem. Lett. 2008, 18, 5406-5410;
26. d) D. P. Walker, M. P. Zawistoski, M. A. McGlynn, J.-C. Li, D. W. Kung, P. C. Bonnette, A. Baumann, L. Buckbinder, J. A. Houser, J. Boer, A. Mistry, S. Han, L. Xing, A. Guzman-Perez, Bioorg. Med. Chem. Lett. 2009, 19, 3253-3258;
27. e) W. J. Polvino, (Sapphire Therapeutics), Patent WO 036892A2, 2006;
28. f) U. Luecking, M. Krüger, R. Jautelat, G. Siemeister, (Schering AG), Patent WO 037800A1, 2005;
29. g) U. Luecking, G. Siemeister, R. Jautelat, (Schering AG), Patent WO 099974A1, 2006;
30. h) U. Luecking, D. Nguyen, A. von Bonin, O. von Ahsen, M. Krueger, H. Briem, H. Kettschau, O. Prien, A. Mengel, K. Krolikiewicz, U. Boemer, U. Bothe, I. Hartung, (Schering AG), Patent WO 071455A1, 2007;
31. i) U. Luecking, (Schering AG), European Patent EP 1,710,246A1, 2006;
32. j) U. Luecking, B. Bader, G. Siemeister, (Bayer Schering Pharma), European Patent EP 1,803,723A1, 2007;
33. k) O. Prien, N. Schmees, K. Eis, J. Guenther, D. Brohm, V. Voehringer, M.-J. Volkhart, H. Beck, M. Lobell, S. Greschat, D. Lang, (Bayer Schering Pharma), Patent WO 080200A1, 2009;
34. l) S. J. Shetty, G. D. Patel, B. B. Lohray, V. B. Lohray, G. Chakrabarti, A. Chatterjee, M. R. Jain, P. R. Patel, (Cadila Healthcare Limited), Patent WO 077574A2, 2007;
35. m) V. B. Pandya, P. R. Patel, (Cadila Healthcare Limited), Patent WO 053999, 2009;
36. n) H. Yu, Z. Qin, H. Dai, X. Zhang, X. Qin, T. Wang, J. Fang, J. Agric. Food Chem. 2008, 56, 11356-11360.
37. For reviews on synthetic approaches to sulfoximines, see: a) C. R. Johnson, Acc. Chem. Res. 1973, 6, 341-347;
38. b) Methoden der Organischen Chemie (Houben-Weyl), Vol. E11, parts 1-2, (Ed.: D. Klamann), Georg Thieme Verlag, Stuttgart, 1985;
39. c) S. Pyne, Sulfur. Rep. 1992, 12, 57-89;
40. d) M. Mikolajczk, J. Drabowicz, P. Kielbasinski, in: Chiral Sulfur Reagents, Boca Raton, CRC Press, 1997;
41. e) P. C. Taylor, Sulfur Rep. 1999, 21, 241-280;
42. f) M. Reggelin, C. Zur, Synthesis 2000, 1-64;
43. g) R. Bentley, Chem. Soc. Rev. 2005, 34, 609-624.
44. a) O. García Mancheño, C. Bolm, Org. Lett. 2006, 8, 2349-2352;
45. b) O. García Mancheño, C. Bolm, Chem. Eur. J. 2007, 13, 6674-6681;
46. c) O. García Mancheño, J. Dallimore, A. Plant, C. Bolm, Org. Lett. 2009, 11, 2429-2432. For previously reported Fe-catalyzed iminations, see:
47. d) T. Bach, C. Kçrber, Tetrahedron Lett. 1998, 39, 5015-5016;
48. e) T. Bach, C. Körber, Eur. J. Org. Chem. 1999, 64, 1033-1039.
49. For reviews on iron catalysis, see: a) C. Bolm, J. Legros, J. Le Paih, L. Zani, Chem. Rev. 2004, 104, 6217-6254;
50. b) A. Fürstner, R. Martin, Chem. Lett. 2005, 624-629;
51. c) D. D. Diaz, P. O. Miranda, J. I. Padrón, V. S. Martin, Curr. Org. Chem. 2006, 10, 457-476;
52. d) S. Enthaler, K. Junge, M. Beller, Angew. Chem. 2008, 120, 3363-3367;
53. Angew. Chem. Int. Ed. 2008, 47, 3317-3321;
54. e) B. D. Sherry, A. Fürstner, Acc. Chem. Res. 2008, 41, 1500-1511;
55. f) E. B. Bauer, Curr. Org. Chem. 2008, 12, 1341-1369;
56. g) S. Gaillard, J.-L. Renaud, ChemSusChem 2008, 1, 505-509;
57. h) A. Correa, O. García Mancheño, C. Bolm, Chem. Soc. Rev. 2008, 37, 1108-1117;
58. i) A. Fürstner, Angew. Chem. 2009, 121, 1390-1393;
59. Angew. Chem. Int. Ed. 2009, 48, 1364-1367;
60. j) W. M. Czaplik, M. Mayer, J. Cvengroš, A. J. vonWangelin, ChemSusChem 2009, 2, 396-417.
61. For other metal-catalyzed sulfur iminations, see: Cu catalysis: a) H. Kwart, A. A. Kahn, J. Am. Chem. Soc. 1967, 89, 1950-1951;
62. b) J. F. K. Müller, P. Vogt, Tetrahedron Lett. 1998, 39, 4805-4806;
63. c) C. Bolm, K. Muñiz, N. Aguilar, M. Kesselgruber, R. Raabe, Synthesis 1999, 1251-1260;
64. d) H. Takada, K. Ohe, S. Uemura, Angew. Chem. 1999, 111, 1367-1369;
65. Angew. Chem. Int. Ed. 1999, 38, 1288-1289;
66. e) J. Nakayama, T. Otani, Y. Sugihara, Y. Sano, A. Ishii, A. Sakamoto, Heteroat. Chem. 2001, 12, 333-348;
67. f) S. Cren, T. C. Kinahan, C. L. Skinner, H. Tye, Tetrahedron Lett. 2002, 43, 2749-2751;
68. g) E. Lacte, M. Amatore, L. Fensterbank, M. Malacria, Synlett 2002, 116 - 118; Rh catalysis:
69. h) H. Okamura, C. Bolm, Org. Lett. 2004, 6, 1305-1308; Ag catalysis:
70. i) G. Y. Cho, C. Bolm, Org. Lett. 2005, 7, 4983-4985.
71. a) O. García Mancheño, O. Bistri, C. Bolm, Org. Lett. 2007, 9, 3809-3811. For alternative metal-free sulfur iminations, see:
72. b) G. Y. Cho, C. Bolm, Tetrahedron Lett. 2005, 46, 8007-8008;
73. c) T. Siu, C. J. Picard, A. K. Yudin, J. Org. Chem. 2005, 70, 932-937;
74. d) S. Karabuga, C. Kazaz, H. Kilic, S. Ulukanli, A. Celik, Tetrahedron Lett. 2005, 46, 5225-5227;
75. e) L. B. Krasnova, R. M. Hili, O. V. Chernoloz, A. K. Yudin, Arkivoc 2005, iv, 26-38.
76. For previous syntheses of N-cyano sulfilimines, see: a) D. Swern, I. Ikeda, G. F. Whitfield, Tetrahedron Lett. 1972, 13, 2635-2638;
77. b) J. E. G. Kemp, D. Ellis, M. D. Closier, Tetrahedron Lett. 1979, 20, 3781-3788;
78. c) M. G. K. Hutchins, D. Swern, Tetrahedron Lett. 1981, 22, 4599-4602;
79. [3c]
80. For examples of 4,5-disubstituted pyrazole syntheses, see: a) J. Becher, P. L. Jørgensen, K. Pluta, N. J. Krake, B. Fält-Hansen, J. Org. Chem. 1992, 57, 2127-2134;
81. b) M.-S. Park, H.-J. Park, K. H. Park, K.-I. Lee, Synth. Commun. 2004, 34, 1541-1550.
82. 2NH, see: M. P. Sibi, G. Petrovic, Tetrahedron: Asymmetry 2003, 14, 2879-2882.
83. See, for example: J. E. G. Kemp, M. D. Closier, M. H. Stefaniak, Tetrahedron Lett. 1979, 20, 3785-3788.
84. P. Stoss, G. Satzinger, Tetrahedron Lett. 1973, 14, 267-268.
85. For the conversion of sulfoximines to sulfones, see: a) J. Hachtel, H.-J. Gais, Eur. J. Org. Chem. 2000, 1457-1465;
86. b) H.-J. Gais, G. S. Babu, M. Guenter, P. Das, Eur. J. Org. Chem. 2004, 1464-1473;
87. c) N. L. Subasinghe, S. Ballentine, J. M. Travins, E. M. Khalil, F. Ali, K. A. Leonard, J. M. Gushue, M. P. Winters, H. Hufnagel, M. D. Cummings, (Janssen Pharmaceutica), Patent WO 101860A1, 2006;
88. d) A. Rajender, H.-J. Gais, Org. Lett. 2007, 9, 579-582.
89. During the type-setting process a study focusing on the synthesis of aryl benzyl NH-sulfoximes was published. N. Barry, N. Brondel, S. E. Lawrence, A. R. Maguire, Tetrahedron 2009, 65, 10660-10670.